A multicenter evaluation of the safety of drotrecogin alfa (activated) in patients with baseline bleeding precautions.
A multicenter evaluation of the safety of drotrecogin alfa (activated) in patients with baseline bleeding precautions. Curr Drug Saf. 2012 Feb; 7(1):3-7.